Literature DB >> 19043726

Prognostic significance of keratinization in squamous cell cancer of uterine cervix: a population based study.

Sanjeev Kumar1, Jay P Shah, Christopher S Bryant, Anthony N Imudia, Rouba Ali-Fehmi, John M Malone, Robert T Morris.   

Abstract

PURPOSE: To determine the influence of keratinization on prognosis in squamous cell cancer (SCC) of the uterine cervix.
METHODS: Patients with keratinized squamous cell carcinoma (KSCC) and non-keratinized squamous cell carcinoma (NKSCC) of the cervix were identified from the Limited Use SEER database from 1988 to 2004. A subgroup of patients who did not have radiation or surgery formed the basis to study the natural history of the disease. Data were analyzed using Pearson Chi-square, Student's T tests. Kaplan-Meier and Cox Regression Proportional Hazards survival analysis was conducted in SPSS and SEER-Stat software.
RESULTS: The KSCC group had 3,102 and the NKSCC had 3,751 patients with mean age being 51 and 49 years, respectively (P = 0.001). In general, patients with KSCC were more likely to have advanced stage (FIGO III and IV) disease while patients with NKSCC were more likely to have poorly differentiated neoplasms (P < 0.001). The prevalence of lymph node metastasis remained similar in both histology types (P > 0.05). Overall, the 5-year survival in KSCC was 63.4% as compared to 65.3% in the NKSCC group (P = 0.04). Patients treated by surgery had no difference in survival; however, patients treated by radiation had a median survival in KSCC of 33 months (n = 928, 95% CI 27.7-38.3) as compared to 38 months (n = 1,140, 95% CI 32.1-43.8) in NKSCC (P = 0.03). A total of 165 KSCC and 147 NKSCC patients did not receive treatment. Within this subgroup, the median survival was 10 months (95% CI 5.93-14.07) as compared to 28 months (95% CI 17.9-38.0; P = 0.001) respectively for the two cohorts. In multivariate analysis stage, treatment status, nodal metastasis and keratinization were independent predictors of survival (P < 0.05).
CONCLUSION: This is the largest study reporting on the prognostic importance of keratinization in SCC. KSCC may be less radiosensitive and associated with shorter overall survival. Also, in the natural history of the SCC, keratinization signifies striking reduction in survival.

Entities:  

Mesh:

Year:  2008        PMID: 19043726     DOI: 10.1007/s00404-008-0851-9

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  6 in total

1.  Influence of MDM2 polymorphisms on squamous cell carcinoma susceptibility: a meta-analysis.

Authors:  Huanxin Yu; Haiyan Li; Jinling Zhang; Gang Liu
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

2.  Role of Cancer Stem Cell, Apoptotic Factor, DNA Repair, and Telomerase Toward Radiation Therapy Response in Stage IIIB Cervical Cancer.

Authors:  Lisnawati Rachmadi; Nurjati Chairani Siregar; Mpu Kanoko; Andrijono Andrijono; Saptawati Bardosono; Dwi Anita Suryandari; Sri Mutya Sekarutami; Bethy Suryawathy Hernowo
Journal:  Oman Med J       Date:  2019-05

3.  Programme death ligand 1 expressions as a surrogate for determining immunotherapy in cervical carcinoma patients.

Authors:  Sebastian A Omenai; Mustapha A Ajani; Clement A Okolo
Journal:  PLoS One       Date:  2022-02-09       Impact factor: 3.240

4.  Human papillomavirus, p16(INK4A), and Ki-67 in relation to clinicopathological variables and survival in primary carcinoma of the vagina.

Authors:  K Hellman; D Lindquist; C Ranhem; E Wilander; S Andersson
Journal:  Br J Cancer       Date:  2014-02-13       Impact factor: 7.640

5.  Integration of gene interaction information into a reweighted random survival forest approach for accurate survival prediction and survival biomarker discovery.

Authors:  Wei Wang; Wei Liu
Journal:  Sci Rep       Date:  2018-09-04       Impact factor: 4.379

6.  Knowledge and awareness of cervical cancer in Southwestern Ethiopia is lacking: A descriptive analysis.

Authors:  Atif Saleem; Alemayehu Bekele; Megan B Fitzpatrick; Eiman A Mahmoud; Athena W Lin; H Eduardo Velasco; Mona M Rashed
Journal:  PLoS One       Date:  2019-11-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.